Cyanocobalamin Injection Market

Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.

Cyanocobalamin Injection Market contains market size and forecasts of Cyanocobalamin Injection in global, including the following market information:

• Global Cyanocobalamin Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Cyanocobalamin Injection Market Sales, 2017-2022, 2023-2028, (K Doses)
• Global top five Cyanocobalamin Injection companies in 2021 (%)

The global Cyanocobalamin Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vitamins Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cyanocobalamin Injection include Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, Jamieson, Teva(Actavis), Merck and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyanocobalamin Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cyanocobalamin Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Cyanocobalamin Injection Market Segment Percentages, by Type, 2021 (%)

• Vitamins
• Supplements

Global Cyanocobalamin Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Cyanocobalamin Injection Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Cyanocobalamin Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Cyanocobalamin Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cyanocobalamin Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cyanocobalamin Injection revenues share in global market, 2021 (%)
• Key companies Cyanocobalamin Injection sales in global market, 2017-2022 (Estimated), (K Doses)
• Key companies Cyanocobalamin Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Luitpold Pharmaceuticals
• Luitpold Pharmaceuticals(Daiichi Sankyo)
• Endo International
• Bristol-Myers Squibb
• Sanofi-Aventis
• Jamieson
• Teva(Actavis)
• Merck
• Mylan
• Bayer HealthCare
• Pfizer
• ANGELINI
• Biological E
• CCEPCD
• Huaxin Pharmaceutical